CD4 and neoplasm: Interestingly, in tumor-bearing mice, CD4+ CD19-CAR T-cells exhibited higher anti-CD19 activity and outperformed CD8+ CAR T-cells especially in the context of higher tumor burden, suggesting that CD4+ CAR T-cells are less prone to exhaustion (232).